Xiao‐Dong Mo

机构：Peking University, Peking University People's Hospital · ORCID：0000-0002-9881-7945

发表论文 464 篇 · 总被引 5170 次 · h-index 39

代表论文

• Acute Myeloid Leukemia Patients With Myelodysplasia-Related Gene Mutations Benefit From Post-Transplant Hypomethylating Agent Maintenance (2025 · Transplantation and Cellular Therapy · 被引 2)
• The PI3K–AKT pathway mediates the imbalance of bone marrow macrophage polarization in patients with immune thrombocytopenia (2026 · Journal of Translational Medicine · 被引 1)
• Do all roads lead to Rome? The heterogeneity of relapsed/refractory diffuse large B-cell lymphoma patients who achieved therapies response and received autologous stem cell transplantation in the era of new targeted drugs (2025 · Cell Transplantation · 被引 1)
• TDI01 in the treatment of moderate to severe chronic graft-versus-host disease: Updated results from a multicenter, OPEN-label phase IB/II study (An Update) (2025 · Blood · 被引 1)
• Oral iptacopan demonstrates efficacy as salvage therapy for high-risk transplant-associated thrombotic microangiopathy: First real-world experience (2025 · Blood · 被引 1)
• Impacts of IPSS-M and transplant conditioning intensity in allogeneic stem cell transplant for myelodysplastic neoplasms (2026 · Bone Marrow Transplantation)